-
Zhonghua yi xue za zhi · Jun 2011
[Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
- Yue Li, Bing-sheng Sun, Zhen-fa Zhang, Lian-min Zhang, and Chang-li Wang.
- Department of Lung Cancer, Tianjin Medical University, Tianjin 300060, China.
- Zhonghua Yi Xue Za Zhi. 2011 Jun 28;91(24):1682-6.
ObjectiveTo investigate the relationship between the metastatic lymph node ratio (LNR) and the prognosis of non-small cell lung cancer (NSCLC).MethodsA total of 301 patients with N1 and N2 NSCLC undergoing curative pulmonectomy were analyzed retrospectively. There were 103 females and 198 males with a median age of 59 years (range: 31 - 78). The correlations between LNR and clinicopathological data were analyzed by χ(2) test. The effects of LNR on overall survival (OS) and disease free survival (DFS) of patients were analyzed by the methods of univariate Kaplan-Meier and multivariate Cox proportional hazard model. The risk groups were classified by LNR on the basis of N staging.ResultsLNR correlated with age, smoking status, pathological type, clinical stage and N stage (P < 0.05). And it also correlated with positive lymph nodes, resected lymph nodes and the number of positive lymph node station (P < 0.001). Kaplan-Meier survival analysis revealed that LNR influenced significantly the lengths of OS (P < 0.001) and DFS (P < 0.001). Cox proportional hazard model showed a high LNR was an independent poor prognostic factor for OS (HR = 2.507, 95%CI 1.612 - 3.900, P < 0.001) and DFS (HR = 1.872, 95%CI 1.182 - 2.964, P = 0.008); and at the same N stage, the low-LNR group was better in OS and DFS than the high-LNR group. After stratification into high-, medium- and low-risk groups, the high- (LNR: > 18%, N-status: N2), intermediate- (LNR: > 18%, N-status: N1; LNR: < 18%, N-status: N2) and low-risk factors (LNR: < 18%, N-status: N1) could efficiently predict the outcomes. The 5-year survival rate (32.8% vs 20.7% vs 6.9%), median survival time (MST) (57 vs 30 vs 16 months), 5-year disease-free survival rate (28.1% vs 16.3% vs 5.5%) and disease-free survival time (38 vs 19 vs 10 months) decreased progressively with the rising risk groups (P < 0.001).ConclusionLNR may be used to accurately predict the prognosis, guide the treatment of NSCLC and improve its staging.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*
,_underline_
or**bold**
. - Superscript can be denoted by
<sup>text</sup>
and subscript<sub>text</sub>
. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3.
, hyphens-
or asterisks*
. - Links can be included with:
[my link to pubmed](http://pubmed.com)
- Images can be included with:
![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
- For footnotes use
[^1](This is a footnote.)
inline. - Or use an inline reference
[^1]
to refer to a longer footnote elseweher in the document[^1]: This is a long footnote.
.